Have you ever wondered if there is a way to heal bones without having to take bone from another part of the body? A new ...

One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting ...

Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable ...

How alterations in cell metabolism translate into specific developmental gene programs remains a major question. This study ...

Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC) space, began with its founders ...

Known as CPMAC, the molecule's inclusion in perovskite solar cells delivers a power conversion efficiency of 26%.

Researchers are developing the biomaterial as a more environmentally friendly alternative to concrete, but any wide-scale use ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

The €500 million deal is Tessellate's first with a pharmaceutical company and focuses on advancing synthetic lethality therapies ...

A new study in Science shows that the incorporation of a synthetic molecule into the design enhances the energy efficiency ...

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic ...

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.